Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 677017-23-1
2. Wp 769
3. Berubicin [inn]
4. 6qpn83hk2m
5. (7s,9s)-7-[(2r,4s,5s,6s)-4-amino-6-methyl-5-phenylmethoxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione
6. Unii-6qpn83hk2m
7. Wp-769
8. Berubicin [who-dd]
9. Chembl2110580
10. Dtxsid70217986
11. Zinc72267022
12. Bb178714
13. Q27265347
14. (8s,10s)-10-((3-amino-4-o-benzyl-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy)-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
15. 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-4-o-(phenylmethyl)-.alpha.-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s,10s)-
| Molecular Weight | 633.6 g/mol |
|---|---|
| Molecular Formula | C34H35NO11 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | 633.22101093 g/mol |
| Monoisotopic Mass | 633.22101093 g/mol |
| Topological Polar Surface Area | 195 Ų |
| Heavy Atom Count | 46 |
| Formal Charge | 0 |
| Complexity | 1130 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Berubicin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Berubicin, including repackagers and relabelers. The FDA regulates Berubicin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Berubicin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Berubicin supplier is an individual or a company that provides Berubicin active pharmaceutical ingredient (API) or Berubicin finished formulations upon request. The Berubicin suppliers may include Berubicin API manufacturers, exporters, distributors and traders.
Berubicin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Berubicin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Berubicin GMP manufacturer or Berubicin GMP API supplier for your needs.
A Berubicin CoA (Certificate of Analysis) is a formal document that attests to Berubicin's compliance with Berubicin specifications and serves as a tool for batch-level quality control.
Berubicin CoA mostly includes findings from lab analyses of a specific batch. For each Berubicin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Berubicin may be tested according to a variety of international standards, such as European Pharmacopoeia (Berubicin EP), Berubicin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Berubicin USP).
LOOKING FOR A SUPPLIER?
